Crossmark

Overexpression of CLC-3 is regulated by XRCC5 and is a poor prognostic biomarker for gastric cancer

Crossref DOI link: https://doi.org/10.1186/s13045-018-0660-y

Published Online: 2018-09-14

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Gu, Zhuoyu

Li, Yixin

Yang, Xiaoya

Yu, Meisheng

Chen, Zhanru

Zhao, Chan

Chen, Lixin

Wang, Liwei http://orcid.org/0000-0001-8535-5641
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81272223, 81273539)

Ministry of Education of the People's Republic of China (20124401110009)

Natural Science Foundation of Guangdong Province (2016A030313495)

Science and Technology Programs of Guangdong (2017A050501021, 2013B051000059)
License Information

Text and Data Mining valid from 2018-09-14
More Information

Article History

Received: 21 June 2018

Accepted: 31 August 2018

First Online: 14 September 2018

Ethics approval and consent to participate

: All animal procedures were performed following the Guide for the Care and Use of Laboratory Animals and the Institutional Ethical Guidelines for Animal Experiments developed by Jinan University. All patients’ samples were collected after informed consent in accordance with the Declaration of Helsinki, and the study was approved by the Ethics Committee of Zhengzhou University.

: Not applicable

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.